Almac Plans 500 New Jobs for Northern Ireland
30 September 2009
Research, development and manufacturing company Almac (Northern Ireland) has secured permission for "major expansion plans" that could lead to the creation of over 500 jobs during the next five years. The company has acquired a 5.4 acre site adjacent to its Craigavon headquarters and will shortly embark on the first phase of development there. Last year, its UK staff numbers rose by 15% to 1,426 and US staff by 10% to 762.
Group Chairman Sir Allen McClay said: "This is an exciting time for Almac. Since our foundation in 2001 we have grown at record levels, and we expect this trend to continue over the coming years. With our rapid rate of growth it was important to put proper plans in place and provide the necessary room for Almac to expand."
The company is also presently engaged in construction of its new $112 million North American Headquarters.
Phase III Trials Show Povorcitinib Significantly Improves Hidradenitis Suppurativa Outcomes
March 19th 2025In the Phase III STOP-HS1 and STOP-HS2 trials, results show that patients treated with povorcitinib for hidradenitis suppurativa experienced a ≥50% reduction in the total abscess and inflammatory nodule count.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
